Ami Fadia's Stock Ratings

Needham Analyst

Ami Fadia is an analyst at Needham. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

13.1%

Smart Score

70.6%

Overall Average Return Percentile

67th

Number of Ratings

211
Buy NowGet Alert
05/13/2024MRUSBuy Now
Merus
$45.0246.6% → $66ReiteratesBuy → BuyGet Alert
05/09/2024AVDLBuy Now
Avadel Pharmaceuticals
$15.5541.48% → $22ReiteratesBuy → BuyGet Alert
05/09/2024RVMDBuy Now
Revolution Medicines
$38.9917.98% → $46ReiteratesBuy → BuyGet Alert
05/09/2024ACADBuy Now
ACADIA Pharmaceuticals
$14.89101.48% → $30ReiteratesBuy → BuyGet Alert
05/08/2024AVDLBuy Now
Avadel Pharmaceuticals
$15.5541.48% → $22ReiteratesBuy → BuyGet Alert
05/08/2024IMRXBuy Now
Immuneering
$1.61831.68% → $15ReiteratesBuy → BuyGet Alert
05/08/2024COGTBuy Now
Cogent Biosciences
$7.20150% → $18ReiteratesBuy → BuyGet Alert
05/08/2024ITCIBuy Now
Intra-Cellular Therapies
$66.5335.28% → $90ReiteratesBuy → BuyGet Alert
05/07/2024ITCIBuy Now
Intra-Cellular Therapies
$66.5335.28% → $90Reiterates → BuyGet Alert
05/07/2024DAWNBuy Now
Day One Biopharmaceutical
$15.74109.65% → $33ReiteratesBuy → BuyGet Alert
05/03/2024BPMCBuy Now
Blueprint Medicines
$106.6421.91%$97 → $130MaintainsBuyGet Alert
05/02/2024BPMCBuy Now
Blueprint Medicines
$106.64-9.04% → $97ReiteratesBuy → BuyGet Alert
05/02/2024JAZZBuy Now
Jazz Pharmaceuticals
$110.49100.92% → $222ReiteratesBuy → BuyGet Alert
05/02/2024NBIXBuy Now
Neurocrine Biosciences
$141.91——Reiterates → HoldGet Alert
05/01/2024NBIXBuy Now
Neurocrine Biosciences
$141.91——Reiterates → HoldGet Alert
05/01/2024HRMYBuy Now
Harmony Biosciences
$29.3177.41%$50 → $52MaintainsBuyGet Alert
04/30/2024HRMYBuy Now
Harmony Biosciences
$29.3170.59% → $50ReiteratesBuy → BuyGet Alert
04/26/2024BPMCBuy Now
Blueprint Medicines
$106.64-9.04% → $97ReiteratesBuy → BuyGet Alert
04/26/2024SAGEBuy Now
Sage Therapeutics
$12.10——Reiterates → HoldGet Alert
04/25/2024SAGEBuy Now
Sage Therapeutics
$12.10——Reiterates → HoldGet Alert
04/25/2024BIIBBuy Now
Biogen
$230.0427.8% → $294ReiteratesBuy → BuyGet Alert
04/25/2024DAWNBuy Now
Day One Biopharmaceutical
$15.74109.65% → $33ReiteratesBuy → BuyGet Alert
04/24/2024BIIBBuy Now
Biogen
$230.0427.8% → $294ReiteratesBuy → BuyGet Alert
04/24/2024DAWNBuy Now
Day One Biopharmaceutical
$15.74109.65%$30 → $33MaintainsBuyGet Alert
04/23/2024NBIXBuy Now
Neurocrine Biosciences
$141.91——Reiterates → HoldGet Alert
04/22/2024ITCIBuy Now
Intra-Cellular Therapies
$66.5335.28%$82 → $90MaintainsBuyGet Alert
04/18/2024SAGEBuy Now
Sage Therapeutics
$12.10——Reiterates → HoldGet Alert
04/16/2024ITCIBuy Now
Intra-Cellular Therapies
$66.5323.25% → $82ReiteratesBuy → BuyGet Alert
04/12/2024IMRXBuy Now
Immuneering
$1.61831.68% → $15ReiteratesBuy → BuyGet Alert
04/12/2024RVMDBuy Now
Revolution Medicines
$38.9917.98%$36 → $46MaintainsBuyGet Alert